Analysis

Jaguar Health, Inc. (JAGX) Stock Analysis

Jaguar Health, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to JAGX.

websiteJAGX/analysis/JAGX

Jaguar Health, Inc.

Jaguar Health, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to JAGX.

Stock profile

Ticker

JAGX

Asset type

Stock

Market cap

$1.4M

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

USD

Ticker listings

Jaguar Health, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • JAGX primary listing
  • 1JA1
  • 1JA

Latest Jaguar Health, Inc. news

Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induc...

Jaguar's recently completed pivotal effectiveness study of crofelemer for the treatment of CID in dogs demonstrates positive, statistically significant results SAN FRANCISCO, CA...

Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program

Reminder: Lisa Conte, Jaguar's founder & CEO, to present on June 24, 2026 at the Life Sciences Virtual Investor Forum to provide updates on company's crofelemer development prog...

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca...

Whole leaf coca extract under evaluation is Magdalena's drug candidate for post-GLP-1 weight loss management SAN FRANCISCO, CA / ACCESS Newswire / June 18, 2026 /Jaguar Health, ...

Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development...

Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Dis...

Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders

Jaguar Health Reports Approval of All Proposals at 2026 Annual Meeting of Stockholders

Research sections

Valuation

Review valuation context for Jaguar Health, Inc..

Future growth

Review future growth context for Jaguar Health, Inc..

Past performance

Review past performance context for Jaguar Health, Inc..

Financial health

Review financial health context for Jaguar Health, Inc..

Dividend

Review dividend context for Jaguar Health, Inc..

Management

Review management context for Jaguar Health, Inc..

Ownership

Review ownership context for Jaguar Health, Inc..

Other information

Review other information context for Jaguar Health, Inc..

Community

Review community context for Jaguar Health, Inc..